What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?

By Puig-Junoy Jaume  

Applied Health Economics and Health Policy, Vol. 4, Iss. 2, 2005-01 ,pp. : 87-98

Adis International

Access to resources Recommend Favorite

Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers' Pricing Strategies and Price Regulation

By Stargardt Tom   Schreyögg Jonas  

Applied Health Economics and Health Policy, Vol. 5, Iss. 4, 2006-01 ,pp. : 235-247

Adis International

Access to resources Recommend Favorite

Public and Decision Maker Stated Preferences for Pharmaceutical Subsidy Decisions: A Pilot Study

By Whitty Jennifer A.  

Applied Health Economics and Health Policy, Vol. 9, Iss. 2, 2011-03 ,pp. : 73-79

Adis International

Access to resources Recommend Favorite

The role of economic evaluation in the pricing and reimbursement of medicines

By Drummond M.   Jonsson B.   Rutten F.  

Health Policy, Vol. 40, Iss. 3, 1997-06 ,pp. : 199-215

Elsevier

Access to resources Recommend Favorite

A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis

By Murray Elizabeth   McAdam Rodney   Burke Moira T  

International Journal of Health Care Quality Assurance, Vol. 17, Iss. 7, 2004-07 ,pp. : 389-393

Emerald Group Publishing Ltd

Access to resources Recommend Favorite